← back to search

Kira Oleinikov

Hadassah Medical Center · IL
Area of research
Epidemiology · Oncology
Research interest
Research interests include Neuroendocrine Tumor Research Advances, Lung Cancer Research Studies, Neuroblastoma Research and Treatments, and Radiopharmaceutical Chemistry and Applications.
h-index
13
citations
590
works
52
NIH funding
primary concept
Medicine
email

Recent publications

Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1–2 cm in size: a retrospective, Europe-wide, pooled cohort study
The Lancet Oncology 2023cited by 64position: middledoi
A Comparison of Outcomes in Medullary Thyroid Carcinoma Patients With and Without a Preoperative Diagnosis: A Multicenter Retrospective Cohort Study
Thyroid 2023cited by 6position: firstdoi
Deliberate Compensated Vasoplegia–A Novel Pharmaceutical Approach for Controlling Blood Pressure During Surgery for Pheochromocytoma
World Journal of Surgery 2023cited by 2position: middledoi
Clinical and pathologic characteristics of appendiceal neuroendocrine neoplasms diagnosed during pregnancy
Frontiers in Endocrinology 2023cited by 2position: middledoi
Pancreatic metastases in patients with neuroendocrine neoplasms: A <scp>multi‐centre</scp> cohort study
Journal of Neuroendocrinology 2023cited by 2position: middledoi
Plasma Progastrin-Releasing Peptide and Chromogranin A Assays for Diagnosing and Monitoring Lung Well-Differentiated Neuroendocrine Tumors: A Brief Report
Journal of Thoracic Oncology 2022cited by 10position: middledoi
Prognostic Factors in Advanced Adrenocortical Carcinoma: Summary of a National Referral Center’s 20 years of Experience
Journal of the Endocrine Society 2022cited by 3position: middledoi
Efficacy and Safety of <sup>177</sup>Lu-DOTATATE in Lung Neuroendocrine Tumors: A Bicenter study
Journal of Nuclear Medicine 2021cited by 46position: middledoi
Metastatic Medullary Thyroid Cancer: The Role of 68Gallium-DOTA-Somatostatin Analogue PET/CT and Peptide Receptor Radionuclide Therapy
The Journal of Clinical Endocrinology & Metabolism 2021cited by 30position: middledoi
Simple model for estimation of absorbed dose by organs and tumors after PRRT from a single SPECT/CT study
EJNMMI Physics 2021cited by 26position: middledoi
Can a penalized-likelihood estimation algorithm be used to reduce the injected dose or the acquisition time in 68Ga-DOTATATE PET/CT studies?
EJNMMI Physics 2021cited by 20position: middledoi
The Autophagy Inhibitor Chloroquine, Alone or in Combination with mTOR Inhibitors, Displays Anti-Tumor Effects in In Vitro and In Vivo Lung Carcinoid Models
Cancers 2021cited by 9position: middledoi
Hereditary syndromes associated with neuroendocrine tumors
Current Opinion in Endocrine and Metabolic Research 2021cited by 3position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Simona Grozinsky‐Glasberg · Hebrew University of Jerusalem12 papers (2021–2023)David J. Gross · Hebrew University of Jerusalem6 papers (2021–2022)Amichay Meirovitz · Soroka Medical Center5 papers (2021–2022)Simona Ben‐Haim · Investigators Research Group (United States)3 papers (2021–2021)Benjamin Nisman · Hebrew University of Jerusalem2 papers (2022–2023)Jeremy Godefroy · Hebrew University of Jerusalem2 papers (2021–2021)Alexandre Chicheportiche · Hebrew University of Jerusalem2 papers (2021–2021) · 2 papers (2023–2023)Ofra Maimon · Hebrew University of Jerusalem2 papers (2022–2022)Haggi Mazeh · Hebrew University of Jerusalem2 papers (2023–2023) · 1 papers (2021–2021)Christine Tang · Baylor College of Medicine1 papers (2021–2021)Martin O. Weickert · Charité - Universitätsmedizin Berlin1 papers (2023–2023) · 1 papers (2021–2021) · 1 papers (2023–2023) · 1 papers (2023–2023)Asher Salmon · Hebrew University of Jerusalem1 papers (2022–2022) · 1 papers (2023–2023)Michael Michael · Novartis (Switzerland)1 papers (2021–2021)Daniel J. Weiss · Hebrew University of Jerusalem1 papers (2023–2023)